MGX-001 — IND submission
Q4 2026
Q4 2026 IND Submission Submit IND for first-in-human Phase 1/2 studySource filing
catalyst calendar
METAGENOMI THERAPEUTICS INC · Data as of 2026-10-25
Q4 2026
Q4 2026 IND Submission Submit IND for first-in-human Phase 1/2 studySource filing